Tatiana E. Shelekhin

Person

Acton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Carboxamides as ubiquitin-specific protease inhibitors
- Patent number 12,162,888
- Issue date Dec 10, 2024
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activating pyruvate kinase R
- Patent number 12,122,778
- Issue date Oct 22, 2024
- Novo Nordisk Health Care AG
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
- Patent number 12,071,440
- Issue date Aug 27, 2024
- Novo Nordisk Health Care AG
- Anna Ericsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating sickle cell disease with a pyruvate kinase R activating co...
- Patent number 12,053,458
- Issue date Aug 6, 2024
- Novo Nordisk Health Care AG
- Anna Ericsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating sickle cell disease with a pyruvate kinase R activating co...
- Patent number 11,980,611
- Issue date May 14, 2024
- Novo Nordisk Health Care AG
- Anna Ericsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
- Patent number 11,649,242
- Issue date May 16, 2023
- Forma Therapeutics, Inc.
- Anna Ericsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,524,966
- Issue date Dec 13, 2022
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions for activating pyruvate kinase
- Patent number 11,396,513
- Issue date Jul 26, 2022
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,325,917
- Issue date May 10, 2022
- Valo Health, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
- Patent number 11,014,927
- Issue date May 25, 2021
- Forma Therapeutics, Inc.
- Anna Ericsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,913,753
- Issue date Feb 9, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,889,592
- Issue date Jan 12, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions for activating pyruvate kinase
- Patent number 10,836,771
- Issue date Nov 17, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions for activating pyruvate kinase
- Patent number 10,472,371
- Issue date Nov 12, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions for activating pyruvate kinase
- Patent number 10,208,052
- Issue date Feb 19, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Uses of substituted imidazoheterocycles
- Patent number 8,859,538
- Issue date Oct 14, 2014
- Cara Therapeutics, Inc.
- R. Paul Beckett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors fo...
- Patent number 8,431,695
- Issue date Apr 30, 2013
- Bayer Intellectual Property GmbH
- Stephen O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazoheterocycles
- Patent number 8,431,565
- Issue date Apr 30, 2013
- Cara Therapeutics, Inc.
- R. Paul Beckett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives...
- Patent number 7,759,376
- Issue date Jul 20, 2010
- Bayer HealthCare LLC
- Roger Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazin...
- Patent number 7,517,874
- Issue date Apr 14, 2009
- Cara Therapeutics, Inc.
- R. Paul Beckett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Patent number 6,919,371
- Issue date Jul 19, 2005
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Patent number 6,660,752
- Issue date Dec 9, 2003
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nitrosated and nitrosylated α-adrenergic receptor antagonist...
- Patent number 6,469,065
- Issue date Oct 22, 2002
- NitroMed, Inc.
- David S. Garvey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS
- Publication number 20240391922
- Publication date Nov 28, 2024
- Novo Nordisk Heathcare AG
- Anna Ericsson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS
- Publication number 20240083901
- Publication date Mar 14, 2024
- Forma Therapeutics, Inc.
- Anna ERICSSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING SICKLE CELL DISEASE WITH A PYRUVATE KINASE R ACTIVATING CO...
- Publication number 20230381151
- Publication date Nov 30, 2023
- Forma Therapeutics, Inc.
- Anna ERICSSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X
- Publication number 20230065368
- Publication date Mar 2, 2023
- Forma Therapeutics, Inc.
- Bruce FOLLOWS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATING PYRUVATE KINASE R
- Publication number 20230055923
- Publication date Feb 23, 2023
- Forma Therapeutics, Inc.
- Xiaozhang ZHENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X
- Publication number 20220041597
- Publication date Feb 10, 2022
- FORMA Therapeutics, Inc.
- Bruce Follows
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X
- Publication number 20210346356
- Publication date Nov 11, 2021
- Forma Therapeutics, Inc.
- Maureen LYNES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210323975
- Publication date Oct 21, 2021
- Valo Early Discovery, Inc.
- David J. GUERIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS
- Publication number 20210246143
- Publication date Aug 12, 2021
- Forma Therapeutics, Inc.
- Anna ERICSSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING DEUBIQUITINASE USP25 AND USP28
- Publication number 20210179628
- Publication date Jun 17, 2021
- Valo Early Discovery, Inc.
- David J. GUERIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210047343
- Publication date Feb 18, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE
- Publication number 20210017184
- Publication date Jan 21, 2021
- FORMA Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS
- Publication number 20200069643
- Publication date Mar 5, 2020
- Forma Therapeutics, Inc.
- Anna ERICSSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE
- Publication number 20200031839
- Publication date Jan 30, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20200017525
- Publication date Jan 16, 2020
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20190359628
- Publication date Nov 28, 2019
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE
- Publication number 20190218221
- Publication date Jul 18, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors...
- Publication number 20110294776
- Publication date Dec 1, 2011
- Bayer Healthcare AG
- Stephen O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES...
- Publication number 20110118302
- Publication date May 19, 2011
- Bayer Pharmaceuticals Corporation
- Roger Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF SUBSTITUTED IMIDAZOHETEROCYCLES
- Publication number 20110034443
- Publication date Feb 10, 2011
- CARA THERAPEUTICS, INC.
- R. Paul Beckett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREPARATION AND USE OF BIPHENYL AMINO ACID DERIVATIVES FOR THE TREA...
- Publication number 20100234307
- Publication date Sep 16, 2010
- Bayer HealthCare LLC
- Roger A. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Preparation and Use of Biphenyl Amino Acid Derivatives for the Trea...
- Publication number 20100016295
- Publication date Jan 21, 2010
- Bayer HealthCare LLC
- Roger A. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZOHETEROCYCLES
- Publication number 20090149450
- Publication date Jun 11, 2009
- CARA THERAPEUTICS, INC.
- R. Paul Beckett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZOHETEROCYCLES
- Publication number 20080318935
- Publication date Dec 25, 2008
- CARA THERAPEUTICS, INC.
- R. Paul Beckett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives...
- Publication number 20070265298
- Publication date Nov 15, 2007
- Bayer Pharmaceuticals Corporation
- Roger Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxamic acids useful in the treatment of hyper-proliferative dis...
- Publication number 20060063760
- Publication date Mar 23, 2006
- Bayer Pharmaceuticals Corporation
- Yamin Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist co...
- Publication number 20050187222
- Publication date Aug 25, 2005
- NitroMed, Inc.
- David S. Garvey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Publication number 20040072828
- Publication date Apr 15, 2004
- Bayer Pharmaceuticals Corporation
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...
- Publication number 20030078260
- Publication date Apr 24, 2003
- Stephen J. O'Connor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nitrosated and nitrosylated alpha-adrenergic receptor antagonists,...
- Publication number 20020143007
- Publication date Oct 3, 2002
- David S. Garvey
- C07 - ORGANIC CHEMISTRY

Tatiana E. Shelekhin

Person

Patents Grantslast 30 patents

Carboxamides as ubiquitin-specific protease inhibitors

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Treating sickle cell disease with a pyruvate kinase R activating co...

Treating sickle cell disease with a pyruvate kinase R activating co...

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Carboxamides as ubiquitin-specific protease inhibitors

Compositions for activating pyruvate kinase

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

Compositions for activating pyruvate kinase

Compositions for activating pyruvate kinase

Compositions for activating pyruvate kinase

Uses of substituted imidazoheterocycles

Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors fo...

Substituted imidazoheterocycles

Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives...

Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazin...

2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor...

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

Nitrosated and nitrosylated &#x03B1;-adrenergic receptor antagonist...

Patents Applicationslast 30 patents

PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS

PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS

TREATING SICKLE CELL DISEASE WITH A PYRUVATE KINASE R ACTIVATING CO...

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X

ACTIVATING PYRUVATE KINASE R

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X

CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS

INHIBITING DEUBIQUITINASE USP25 AND USP28

THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE

PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS

COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE

Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors

Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors

COMPOSITIONS FOR ACTIVATING PYRUVATE KINASE

Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors...

PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES...

USES OF SUBSTITUTED IMIDAZOHETEROCYCLES

PREPARATION AND USE OF BIPHENYL AMINO ACID DERIVATIVES FOR THE TREA...

Preparation and Use of Biphenyl Amino Acid Derivatives for the Trea...

SUBSTITUTED IMIDAZOHETEROCYCLES

SUBSTITUTED IMIDAZOHETEROCYCLES

Preparation and Use of Biphenyl-4-Yl-Carbonylamino Acid Derivatives...

Hydroxamic acids useful in the treatment of hyper-proliferative dis...

Nitrosated and nitrosylated alpha-adrenergic receptor antagonist co...

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor...

Nitrosated and nitrosylated alpha-adrenergic receptor antagonists,...

Nitrosated and nitrosylated α-adrenergic receptor antagonist...